
AVIR Valuation
Atea Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
AVIR Relative Valuation
AVIR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVIR is overvalued; if below, it's undervalued.
Historical Valuation
Atea Pharmaceuticals Inc (AVIR) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -57.71. The fair price of Atea Pharmaceuticals Inc (AVIR) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:3.74
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.73
P/B
Median3y
0.59
Median5y
1.41
-42.99
FCF Yield
Median3y
-36.76
Median5y
-22.08
Competitors Valuation Multiple
The average P/S ratio for AVIR's competitors is 64.33, providing a benchmark for relative valuation. Atea Pharmaceuticals Inc Corp (AVIR) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

DOMO
Domo Inc
16.130
USD
0.00%

GAU
Galiano Gold Inc
1.500
USD
-0.66%

AQST
Aquestive Therapeutics Inc
4.200
USD
-1.41%

FPH
Five Point Holdings LLC
6.430
USD
-0.46%

ARQ
Arq Inc
5.780
USD
+0.52%

FRST
Primis Financial Corp
11.690
USD
-3.39%

RZLT
Rezolute Inc
5.870
USD
-0.17%

BRBS
Blue Ridge Bankshares Inc
3.810
USD
-3.54%

RGP
Resources Connection Inc
5.270
USD
-4.18%

IMMP
Immutep Ltd
1.700
USD
+1.19%
FAQ

Is Atea Pharmaceuticals Inc (AVIR) currently overvalued or undervalued?
Atea Pharmaceuticals Inc (AVIR) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -57.71. The fair price of Atea Pharmaceuticals Inc (AVIR) is between NaN to NaN according to relative valuation methord.

What is Atea Pharmaceuticals Inc (AVIR) fair value?

How does AVIR's valuation metrics compare to the industry average?

What is the current P/B ratio for Atea Pharmaceuticals Inc (AVIR) as of Jul 25 2025?

What is the current FCF Yield for Atea Pharmaceuticals Inc (AVIR) as of Jul 25 2025?

What is the current Forward P/E ratio for Atea Pharmaceuticals Inc (AVIR) as of Jul 25 2025?
